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journal homepage: www.jfma-onl ine.comLETTER TO THE EDITORRisk factors for central venous access
port-related infectionTo the Editor,
I read with interest the article by Wang et al1 published
online in the Journal of the Formosan Medical Association.
The authors analyzed the incidence and risk factors for
central venous access port-related infection among Chinese
patients receiving cytotoxic chemotherapy. They found
that infection remained a challenging issue for total
implantable central venous ports. They pointed out that
the implementation of an insertion bundle for preventing
central line-associated bloodstream infections was war-
ranted, especially for those patients with hematological
and head and neck cancers, as well as for patients receiving
chemotherapy in metastatic settings. I would like to
congratulate the authors on this pioneering and well-
written article on Chinese cancer patients. However, I
consider that some explanation regarding the details of the
patient population would be beneficial.
The density of skin flora at the catheter insertion site is
defined as a major risk factor for catheter-related blood-
stream infections of central venous catheters according to
the Center for Disease Control and Prevention Guidelines.2
Also, there are some other accepted risk factors including
male sex, hematologic malignancy, previous blood stream
infection, the state of receiving palliative chemotherapy,
neutropenia, parenteral nutrition, higher Karnofsky score,
chronic steroid use, metastasis of the primary cancer,
increased catheter-time, and severe sepsis at onset.2e4 The
authors have analyzed age, sex, disease status, primary
tumor location, chemotherapy setting, time of catheter
insertion, and the cause of catheter failure related to pa-
tients characteristics. However, some of the conditions and
risk factors known to be associated with central venous
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formation to prevent Asian patients from central venous
access port-related infections, I think that knowledge of
these risk factors in the patient population would be valu-
able and interesting to the readers.
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